156 related articles for article (PubMed ID: 3829496)
1. Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity.
Peppoloni S; Herberman RB; Gorelik E
Clin Exp Metastasis; 1987; 5(1):43-56. PubMed ID: 3829496
[TBL] [Abstract][Full Text] [Related]
2. Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation.
Peppoloni S; Herberman RB; Gorelik E
Cancer Res; 1985 Jun; 45(6):2560-6. PubMed ID: 2580624
[TBL] [Abstract][Full Text] [Related]
3. The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells.
Eisenbach L; Hollander N; Greenfeld L; Yakor H; Segal S; Feldman M
Int J Cancer; 1984 Oct; 34(4):567-73. PubMed ID: 6490207
[TBL] [Abstract][Full Text] [Related]
4. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
[TBL] [Abstract][Full Text] [Related]
5. Expression of ganglioside GM3 and H-2 antigens in clones with different metastatic and growth potentials isolated from Lewis lung carcinoma (3LL) cell line.
Inokuchi J; Jimbo M; Kumamoto Y; Shimeno H; Nagamatsu A
Clin Exp Metastasis; 1993 Jan; 11(1):27-36. PubMed ID: 8422703
[TBL] [Abstract][Full Text] [Related]
6. Role of NK cells in the control of metastatic spread and growth of tumor cells in mice.
Gorelik E; Wiltrout RH; Okumura K; Habu S; Herberman RB
Int J Cancer; 1982 Jul; 30(1):107-12. PubMed ID: 7118294
[TBL] [Abstract][Full Text] [Related]
7. Loss of expression of transplantation antigens encoded by the H-2K locus on Lewis lung carcinoma cells and its relevance to the tumor's metastatic properties.
Isakov N; Katzav S; Feldman M; Segal S
J Natl Cancer Inst; 1983 Jul; 71(1):139-45. PubMed ID: 6345878
[TBL] [Abstract][Full Text] [Related]
8. Loss of the H-2.33 private specificity by 3LL tumor cells correlates with the tumor potential to metastasize across the H-2K region genetic barriers.
Isakov N; Feldman M; Segal S
Exp Clin Immunogenet; 1984; 1(3):170-4. PubMed ID: 6401004
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of growth and metastases in mice by immunization with cholesterol hemisuccinate-enriched tumor cells.
Skornick Y; Gorelik E; Klausner J; Shinitzky M; Sindelar WF
Cancer Lett; 1984 Dec; 25(2):153-61. PubMed ID: 6509434
[TBL] [Abstract][Full Text] [Related]
10. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.
Isakov N; Feldman M; Segal S
Invasion Metastasis; 1982; 2(1):12-32. PubMed ID: 6765248
[TBL] [Abstract][Full Text] [Related]
11. Adoptively transferred ex vivo activated memory T cells with cyclophosphamide: effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Clin Immunol Immunopathol; 1994 Oct; 73(1):115-22. PubMed ID: 7923908
[TBL] [Abstract][Full Text] [Related]
12. MHC antigens expressed on 3LL metastatic variants: correlation with the expression of a TSP-180 protein.
Sacchi A; Falcioni R; Tibursi G; Apollonj Ghetti C
Adv Exp Med Biol; 1988; 233():141-50. PubMed ID: 3223380
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of tumor cell growth in vitro by a monoclonal antibody to a tumor specific protein (TSP-180) present on the cell surface of 3LL cells.
Sacchi A; Piaggio G; Rizzo MA; Falcioni R; Kennel SJ
Clin Exp Metastasis; 1989; 7(1):41-54. PubMed ID: 2783240
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated antigenic differences between the primary and the descendant metastatic tumor cell populations.
Gorelik E; Fogel M; Segal S; Feldman M
J Supramol Struct; 1979; 12(3):385-402. PubMed ID: 94933
[TBL] [Abstract][Full Text] [Related]
15. Role of natural killer cells in controlling local tumor formation and metastatic manifestation of different 3LL Lewis lung carcinoma cell clones.
Aboud M; Kingsmore S; Segal S
Nat Immun; 1993; 12(1):17-24. PubMed ID: 8431660
[TBL] [Abstract][Full Text] [Related]
16. Differences in resistance of metastatic tumor cells and cells from local tumor growth to cytotoxicity of natural killer cells.
Gorelik E; Fogel M; Feldman M; Segal S
J Natl Cancer Inst; 1979 Dec; 63(6):1397-404. PubMed ID: 292811
[TBL] [Abstract][Full Text] [Related]
17. Characterization of two highly metastatic variants of Lewis lung carcinoma with different organ specificities.
Brodt P
Cancer Res; 1986 May; 46(5):2442-8. PubMed ID: 3697987
[TBL] [Abstract][Full Text] [Related]
18. Effect of Z-100, an immunomodulator extracted from human type tubercle bacilli, on the pulmonary metastases of Lewis lung carcinoma in attempt to regulate suppressor T cells and suppressor factor, IL-4.
Emori Y; Sasaki H; Hayashi Y; Nomoto K
Biotherapy; 1996; 9(4):249-56. PubMed ID: 9012544
[TBL] [Abstract][Full Text] [Related]
19. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation.
Begovic M; Herberman R; Gorelik E
Cancer Res; 1991 Oct; 51(19):5153-9. PubMed ID: 1913641
[TBL] [Abstract][Full Text] [Related]
20. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
